Peer-reviewed veterinary case report
Survival and spread of nasal bone cancer in dogs from 2005-2015
By Galloway, Annie et al.·Published in Journal of the American Animal Hospital Association·2020·From the Department of Clinical Sciences (A.G., United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Outcome and Metastatic Behavior of Canine Sinonasal Osteosarcoma (2005-2015).
- Species:
- dog
Plain-English summary
A group of 27 dogs diagnosed with sinonasal osteosarcoma (a type of bone cancer in the nasal area) was studied to understand how the disease progresses and its potential to spread. About 30% of these dogs developed metastasis (spread of cancer to other parts of the body), with an average time of about 458 days before this occurred. The dogs had a median survival time of around 410 days after diagnosis, regardless of the treatment they received. This suggests that sinonasal osteosarcoma behaves similarly to other nasal tumors, and treatment outcomes are comparable to those of dogs with different types of nasal tumors.
People also search for: dog sinonasal osteosarcoma prognosis · canine nasal cancer treatment · dog cancer survival rates
Abstract
Sinonasal neoplasms in dogs behave locally aggressively, and metastatic disease has not been a common cause of death. The metastatic rate of sinonasal osteosarcoma (OSA) is not well characterized, and reported outcomes of these patients are variable. The purpose of this study is to evaluate the outcome and metastatic behavior of canine sinonasal OSA. Medical records of canine patients diagnosed with sinonasal OSA via histopathology between January 2005 and December 2015 were reviewed. Patients with any form of treatment or no treatment were included. Time to local progression, time to metastasis, and overall survival data were evaluated. Variables that may impact outcome, such as tumor stage and treatment type, were evaluated. Twenty-seven dogs were identified that fit the inclusion criteria. Overall, 30.0% of dogs developed metastasis over the disease course, with a median time to metastasis of 458 days (95% confidence interval [CI] 318-758 days). The median time to local progression was 335 days (95% CI 264-544 days). The overall median survival time was 410 days (95% CI 341-627 days). Regarding metastasis, sinonasal OSA behaves similarly to sinonasal neoplasms of other histologies and dissimilarly to appendicular OSA. The outcome of treated patients appears similar to that of sinonasal tumor patients with other histologies.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/31961217/